Sergio Bracarda
Impact in
- Pulmonary and Respiratory Medicine top 0.05%
- Renal cell carcinoma treatment
- Prostate Cancer Treatment and Research
- Cancer Research top 0.2%
- Cancer Genomics and Diagnostics
Papers in
-
- Renal cell carcinoma treatment 107
- Prostate Cancer Treatment and Research 54
- Oncology 84
- Cancer Immunotherapy and Biomarkers 43
- Cancer Treatment and Pharmacology 13
- Co-authors
- Bernard Escudier (45 shared papers)Alain Ravaud (37 shared papers)Camillo Porta (57 shared papers)Stéphane Oudard (26 shared papers)Robert J. Motzer (24 shared papers)Thomas E. Hutson (18 shared papers)Viktor Grünwald (15 shared papers)Robert A. Figlin (8 shared papers)
- Journals
- Journal of Clinical Oncology (65 papers)Annals of Oncology (28 papers)European Journal of Cancer (11 papers)Critical Reviews in Oncology/Hematology (10 papers)Clinical Genitourinary Cancer (7 papers)
- Partner nations
- ItalyUnited StatesFrance
In The Last Decade
Sergio Bracarda
223 papers receiving 11.5k citations
Sergio Bracarda's Hit Papers
Peers
Comparison fields: 5 of 120
- Pulmonary and Respiratory Medicine 6.8k
- Cancer Research 2.6k
- Oncology 3.2k
- Molecular Biology 4.1k
- Surgery 1.7k
Countries citing papers authored by Sergio Bracarda
This map shows the geographic impact of Sergio Bracarda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sergio Bracarda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sergio Bracarda more than expected).
Fields of papers citing papers by Sergio Bracarda
This network shows the impact of papers produced by Sergio Bracarda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sergio Bracarda. The network helps show where Sergio Bracarda may publish in the future.
Co-authors
The 25 scholars most cited alongside Sergio Bracarda, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 239 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial Hit paper breakdown → | 2008 | 2345 |
| 2 | Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial Hit paper breakdown → | 2007 | 1725 |
| 3 | Nivolumab in metastatic urothelial carcinoma after platinum therapy (CheckMate 275): a multicentre, single-arm, phase 2 trial Hit paper breakdown → | 2017 | 1223 |
| 4 | Phase 3 trial of everolimus for metastatic renal cell carcinoma Hit paper breakdown → | 2010 | 905 |
| 5 | Phase III Trial of Bevacizumab Plus Interferon Alfa-2a in Patients With Metastatic Renal Cell Carcinoma (AVOREN): Final Analysis of Overall Survival Hit paper breakdown → | 2010 | 635 |
| 6 | Safety and efficacy of sunitinib for metastatic renal-cell carcinoma: an expanded-access trial Hit paper breakdown → | 2009 | 457 |
| 7 | 2018 | 229 | |
| 8 | 2011 | 183 | |
| 9 | 2018 | 154 | |
| 10 | 2018 | 121 | |
| 11 | 2010 | 107 | |
| 12 | 2011 | 107 | |
| 13 | 2011 | 106 | |
| 14 | 1991 | 98 | |
| 15 | 2007 | 85 | |
| 16 | 1989 | 83 | |
| 17 | 2005 | 83 | |
| 18 | 1991 | 80 | |
| 19 | 2013 | 77 | |
| 20 | 2014 | 77 |
About Sergio Bracarda
Sergio Bracarda is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Cancer Research, Surgery and Molecular Biology, having authored 239 papers that have together received 11.7k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (107 papers), Prostate Cancer Treatment and Research (54 papers), Cancer Immunotherapy and Biomarkers (43 papers), Cancer Genomics and Diagnostics (41 papers), Bladder and Urothelial Cancer Treatments (26 papers), Renal and related cancers (17 papers), Economic and Financial Impacts of Cancer (17 papers) and Cancer Treatment and Pharmacology (13 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (6.8k citations), Cancer Research (2.6k citations), Oncology (3.2k citations), Molecular Biology (4.1k citations) and Surgery (1.7k citations). Sergio Bracarda has collaborated with scholars based in Italy, United States and France. Frequent co-authors include Bernard Escudier, Alain Ravaud, Camillo Porta, Stéphane Oudard, Robert J. Motzer, Thomas E. Hutson, Viktor Grünwald, Robert A. Figlin, John A. Thompson and Norbert Hollaender. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, European Journal of Cancer, Critical Reviews in Oncology/Hematology and Clinical Genitourinary Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.